Over the last decades, cases of deep dermatophytosis have increased, particularly in immunocompromised patients, such as patients with solid organ transplantation, hematological malignancy, immunosuppressive therapy, CARD9 deficiency, and diabetes mellitus (Marconi et al., 2010; Lanternier et al., 2013). Here, CARD9 is linked to dermatophytosis.